IPP Bureau
Sea Urchin spines inspire breakthrough sensor that detects water flow instantly
By IPP Bureau - March 06, 2026
Their findings, published in the journal Nature, reveal that the spines’ unique porous internal structure allows them to convert water movement into measurable electrical signals
FUJIFILM Biotechnologies launches purification technology for biologics
By IPP Bureau - March 06, 2026
ShunzymeX leverages a proprietary protease to streamline purification
Bayer expands MRXperion power injector capabilities with FDA nod
By IPP Bureau - March 06, 2026
The system also introduces Imaging Scanner Interface 2 (ISI2) capability, enabling direct communication between injector and scanner to improve exam coordination and operational efficiency
FDA okays JUXTAPID for kids with ultra-rare genetic cholesterol disorder
By IPP Bureau - March 06, 2026
Philips unveils next-gen CT system ‘Rembra’
By IPP Bureau - March 06, 2026
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
Alembic enters US branded market with first sales of Pivya UTI treatment
By IPP Bureau - March 06, 2026
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
Granules India’s US packaging facility clears FDA inspection with zero observations
By IPP Bureau - March 06, 2026
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
NATCO announces launch of Pomalidomide capsules in US
By IPP Bureau - March 05, 2026
It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma
Ind-Swift earns EcoVadis silver medal for sustainability excellence
By IPP Bureau - March 05, 2026
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
PK Healthcare granted accreditation under 6th edition by NABH
By IPP Bureau - March 05, 2026
The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems
Shyamakant Giri resigns as CEO of Gland Pharma
By IPP Bureau - March 05, 2026
Giri stated he is stepping down to pursue new opportunities after careful consideration
Teva and Blackstone Life Sciences strike $400m deal to advance promising IBD therapy
By IPP Bureau - March 05, 2026
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Moderna strikes $950 million global settlement with Arbutus & Genevant, clears legal hurdles for vaccine pipeline
By IPP Bureau - March 05, 2026
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
KIMS Hospitals launches India’s first adaptive deep brain stimulation for Parkinson’s patients
By IPP Bureau - March 05, 2026
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention















